Alignment Healthcare, Inc. (NASDAQ: ALHC) Stock Competitors & Peer Comparison
See ALHC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ALHC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALHC | $13.59 | -1.39% | 2.7B | 146.67 | $0.09 | N/A |
| UNH | $404.47 | -1.04% | 365.3B | 24.61 | $16.34 | +2.22% |
| CVS | $94.24 | -1.49% | 119.3B | 11.93 | $7.84 | +2.85% |
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| ELV | $395.25 | -0.62% | 84.7B | 13.28 | $29.39 | +1.76% |
| CI | $276.00 | -0.86% | 72.4B | 8.86 | $30.90 | +2.26% |
| HUM | $387.09 | +0.36% | 44.8B | 23.52 | $15.86 | +0.94% |
| CNC | $66.62 | +0.08% | 32B | 25.74 | $2.52 | N/A |
| MOH | $202.71 | +1.95% | 10.2B | 28.10 | $6.92 | N/A |
| OSCR | $28.83 | +4.19% | 7.2B | 19.97 | $1.40 | N/A |
Stock Comparison
UnitedHealth Group Incorporated (NYSE: UNH)
ALHC vs UNH Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, UNH has a market cap of 365.3B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while UNH trades at $404.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas UNH's P/E ratio is 24.61. In terms of profitability, ALHC's ROE is +0.20%, compared to UNH's ROE of +0.14%. Regarding short-term risk, ALHC is more volatile compared to UNH. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check UNH's competition here
CVS Health Corp. (NYSE: CVS)
ALHC vs CVS Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, CVS has a market cap of 119.3B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while CVS trades at $94.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas CVS's P/E ratio is 11.93. In terms of profitability, ALHC's ROE is +0.20%, compared to CVS's ROE of +0.06%. Regarding short-term risk, ALHC is more volatile compared to CVS. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check CVS's competition here
Elevance Health Inc. (NYSE: ANTM)
ALHC vs ANTM Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, ANTM has a market cap of 114.6B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while ANTM trades at $482.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas ANTM's P/E ratio is 18.99. In terms of profitability, ALHC's ROE is +0.20%, compared to ANTM's ROE of +0.11%. Regarding short-term risk, ALHC is less volatile compared to ANTM. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check ANTM's competition here
Elevance Health Inc. (NYSE: ELV)
ALHC vs ELV Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, ELV has a market cap of 84.7B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while ELV trades at $395.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas ELV's P/E ratio is 13.28. In terms of profitability, ALHC's ROE is +0.20%, compared to ELV's ROE of +0.11%. Regarding short-term risk, ALHC is more volatile compared to ELV. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check ELV's competition here
Cigna Corporation (NYSE: CI)
ALHC vs CI Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, CI has a market cap of 72.4B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while CI trades at $276.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas CI's P/E ratio is 8.86. In terms of profitability, ALHC's ROE is +0.20%, compared to CI's ROE of +0.15%. Regarding short-term risk, ALHC is more volatile compared to CI. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check CI's competition here
Humana Inc. (NYSE: HUM)
ALHC vs HUM Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, HUM has a market cap of 44.8B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while HUM trades at $387.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas HUM's P/E ratio is 23.52. In terms of profitability, ALHC's ROE is +0.20%, compared to HUM's ROE of +0.07%. Regarding short-term risk, ALHC is less volatile compared to HUM. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check HUM's competition here
Centene Corp. (NYSE: CNC)
ALHC vs CNC Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, CNC has a market cap of 32B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while CNC trades at $66.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas CNC's P/E ratio is 25.74. In terms of profitability, ALHC's ROE is +0.20%, compared to CNC's ROE of -0.24%. Regarding short-term risk, ALHC is less volatile compared to CNC. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check CNC's competition here
Molina Healthcare, Inc. (NYSE: MOH)
ALHC vs MOH Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, MOH has a market cap of 10.2B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while MOH trades at $202.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas MOH's P/E ratio is 28.10. In terms of profitability, ALHC's ROE is +0.20%, compared to MOH's ROE of -0.00%. Regarding short-term risk, ALHC is less volatile compared to MOH. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check MOH's competition here
Oscar Health, Inc. (NYSE: OSCR)
ALHC vs OSCR Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, OSCR has a market cap of 7.2B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while OSCR trades at $28.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas OSCR's P/E ratio is 19.97. In terms of profitability, ALHC's ROE is +0.20%, compared to OSCR's ROE of +0.39%. Regarding short-term risk, ALHC is less volatile compared to OSCR. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check OSCR's competition here
Clover Health Investments, Corp. (NASDAQ: CLOV)
ALHC vs CLOV Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, CLOV has a market cap of 2.3B. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while CLOV trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas CLOV's P/E ratio is 102.95. In terms of profitability, ALHC's ROE is +0.20%, compared to CLOV's ROE of -0.05%. Regarding short-term risk, ALHC is more volatile compared to CLOV. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check CLOV's competition here
Bright Health Group, Inc. (NYSE: BHG)
ALHC vs BHG Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas BHG's P/E ratio is -0.12. In terms of profitability, ALHC's ROE is +0.20%, compared to BHG's ROE of +0.04%. Regarding short-term risk, ALHC is less volatile compared to BHG. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check BHG's competition here
Caring Brands, Inc. (NASDAQ: CABR)
ALHC vs CABR Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, CABR has a market cap of 12.9M. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while CABR trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas CABR's P/E ratio is -2.54. In terms of profitability, ALHC's ROE is +0.20%, compared to CABR's ROE of -3.28%. Regarding short-term risk, ALHC is less volatile compared to CABR. This indicates lower risk in terms of short-term price fluctuations for ALHC.Check CABR's competition here
Magellan Health, Inc. (NASDAQ: MGLN)
ALHC vs MGLN Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas MGLN's P/E ratio is 8.49. In terms of profitability, ALHC's ROE is +0.20%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, ALHC is more volatile compared to MGLN. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check MGLN's competition here
Aetna Inc. (NYSE: AET)
ALHC vs AET Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, AET has a market cap of 0. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas AET's P/E ratio is 9.57. In terms of profitability, ALHC's ROE is +0.20%, compared to AET's ROE of +0.11%. Regarding short-term risk, ALHC is more volatile compared to AET. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check AET's competition here
Triple-S Management Corporation (NYSE: GTS)
ALHC vs GTS Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, GTS has a market cap of 0. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas GTS's P/E ratio is 10.41. In terms of profitability, ALHC's ROE is +0.20%, compared to GTS's ROE of +0.07%. Regarding short-term risk, ALHC is more volatile compared to GTS. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check GTS's competition here
Universal American Corporation (NYSE: UAM)
ALHC vs UAM Comparison August 2026
Alignment Healthcare, Inc. (NASDAQ: ALHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALHC stands at 2.7B. In comparison, UAM has a market cap of 0. Regarding current trading prices, ALHC is priced at $13.59 on the NASDAQ, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALHC currently has a P/E ratio of 146.67, whereas UAM's P/E ratio is 1.01. In terms of profitability, ALHC's ROE is +0.20%, compared to UAM's ROE of +0.17%. Regarding short-term risk, ALHC is more volatile compared to UAM. This indicates higher risk in terms of short-term price fluctuations for ALHC.Check UAM's competition here